Evaluation of the use of low-dose quetiapine and the risk of metabolic consequences: A retrospective review

INTRODUCTION: Quetiapine fumarate is an atypical antipsychotic approved for the treatment of schizophrenia, major depressive disorder, and bipolar disorder. Due to the sedative effects observed at low doses, prescribers use quetiapine to aid patients with sleep disturbances. Current evidence has est...

Descripción completa

Detalles Bibliográficos
Autores principales: Carr, Chelsea N., Lopchuk, Shruti, Beckman, Mary E., Baugh, Terrence Bradley
Formato: Online Artículo Texto
Lenguaje:English
Publicado: College of Psychiatric & Neurologic Pharmacists 2016
Materias:
Open Submissions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6007538/
https://www.ncbi.nlm.nih.gov/pubmed/29955487
http://dx.doi.org/10.9740/mhc.2016.11.308

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6007538/
https://www.ncbi.nlm.nih.gov/pubmed/29955487
http://dx.doi.org/10.9740/mhc.2016.11.308

Ejemplares similares